FDA Inspection 1196422 — Marsh Regional Blood Center
The FDA completed an inspection of Marsh Regional Blood Center on December 15, 2022 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 15, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bristol, TN (United States)